Purpose: Correction of valvular pathology is often undertaken in patients undergoing LVAD implantation but impact on outcomes is uncertain. We compared clinical outcomes with HeartMate 3 (HM3) LVAD implantation in those with concurrent valve procedures (VP) to those with an isolated LVAD implant within the MOMENTUM3 trial portfolio, including the Pivotal Trial (n=515, NCT02224755) and Continued Access Protocol/ CAP (n=1685, NCT02892955). Methods: The study included 2200 HM3 implanted patients. Among 820 concurrent procedures (including VP, CABG, RVAD, LAA closure), 466 (21.8%) were VPs (HM3+VP), including 81 aortic, 61 mitral, 163 tricuspid, and 85 patients with multiple VPs. Short and Long-term outcomes including peri-operative complicatio...
Aims: Sufficient myocardial recovery with the subsequent explantation of a left ventricular assist d...
Background The aim of this study was to evaluate the impact of the surgical approach on the postope...
Background: An increasing proportion of patients present for concomitant aortic valve replacement(AV...
BackgroundPreexisting valve pathology is common in patients with end-stage heart failure undergoing ...
Valvular heart disease is common among left ventricular assist device (LVAD) recipients. However, it...
BACKGROUND: Mitral regurgitation (MR) determines pathophysiology and outcome in advanced heart failu...
Aims: Since the withdrawal of HeartWare (HVAD) from the global market, there is an ongoing discussio...
AIMS Continuous-flow left ventricular assist devices (CF-LVADs) have become a standard of care in...
Copyright ©2019 by the ASAIO. There are conflicting data regarding whether concomitant mitral valve ...
Background: Mixed valvular disease (MVD), mitral regurgitation (MR) from pre‐existing disease in con...
INTRODUCTION: AIMS: Left ventricular assist device therapy has become the cornerstone in the treatm...
ObjectivePatients referred for implantable continuous-flow left ventricular assist devices (cfLVAD) ...
Importance: Left ventricular assist devices (LVADs) are well established in the treatment of advance...
ObjectivesThis study sought to assess the effectiveness of a novel percutaneous method to treat left...
BACKGROUND: Several distinctly engineered left ventricular assist devices (LVADs) are in clinical us...
Aims: Sufficient myocardial recovery with the subsequent explantation of a left ventricular assist d...
Background The aim of this study was to evaluate the impact of the surgical approach on the postope...
Background: An increasing proportion of patients present for concomitant aortic valve replacement(AV...
BackgroundPreexisting valve pathology is common in patients with end-stage heart failure undergoing ...
Valvular heart disease is common among left ventricular assist device (LVAD) recipients. However, it...
BACKGROUND: Mitral regurgitation (MR) determines pathophysiology and outcome in advanced heart failu...
Aims: Since the withdrawal of HeartWare (HVAD) from the global market, there is an ongoing discussio...
AIMS Continuous-flow left ventricular assist devices (CF-LVADs) have become a standard of care in...
Copyright ©2019 by the ASAIO. There are conflicting data regarding whether concomitant mitral valve ...
Background: Mixed valvular disease (MVD), mitral regurgitation (MR) from pre‐existing disease in con...
INTRODUCTION: AIMS: Left ventricular assist device therapy has become the cornerstone in the treatm...
ObjectivePatients referred for implantable continuous-flow left ventricular assist devices (cfLVAD) ...
Importance: Left ventricular assist devices (LVADs) are well established in the treatment of advance...
ObjectivesThis study sought to assess the effectiveness of a novel percutaneous method to treat left...
BACKGROUND: Several distinctly engineered left ventricular assist devices (LVADs) are in clinical us...
Aims: Sufficient myocardial recovery with the subsequent explantation of a left ventricular assist d...
Background The aim of this study was to evaluate the impact of the surgical approach on the postope...
Background: An increasing proportion of patients present for concomitant aortic valve replacement(AV...